Walkner Condon Financial Advisors LLC Boosts Position in Procter & Gamble Company (The) $PG
by Renee Jackson · The Cerbat GemWalkner Condon Financial Advisors LLC raised its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 10.2% during the second quarter, HoldingsChannel reports. The institutional investor owned 4,426 shares of the company’s stock after acquiring an additional 408 shares during the quarter. Walkner Condon Financial Advisors LLC’s holdings in Procter & Gamble were worth $705,000 at the end of the most recent quarter.
A number of other hedge funds have also made changes to their positions in PG. Kingstone Capital Partners Texas LLC raised its position in Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Northern Trust Corp raised its holdings in shares of Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after buying an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after acquiring an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Procter & Gamble by 3.5% during the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock valued at $2,966,252,000 after purchasing an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Procter & Gamble by 6.3% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock valued at $2,947,146,000 after purchasing an additional 1,018,865 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Up 0.6%
Shares of Procter & Gamble stock opened at $147.03 on Friday. Procter & Gamble Company has a twelve month low of $144.46 and a twelve month high of $180.43. The stock has a market capitalization of $343.57 billion, a price-to-earnings ratio of 21.44, a PEG ratio of 3.87 and a beta of 0.36. The company has a current ratio of 0.71, a quick ratio of 0.51 and a debt-to-equity ratio of 0.46. The business’s 50 day simple moving average is $153.13 and its 200-day simple moving average is $157.29.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The firm had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. During the same period last year, the company earned $1.93 earnings per share. The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Equities research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be issued a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend is Friday, October 24th. Procter & Gamble’s dividend payout ratio is presently 61.61%.
Analyst Ratings Changes
PG has been the subject of a number of research analyst reports. Wells Fargo & Company dropped their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. UBS Group dropped their target price on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. JPMorgan Chase & Co. increased their price target on shares of Procter & Gamble from $163.00 to $165.00 and gave the stock a “neutral” rating in a research report on Monday, October 27th. Evercore ISI reissued an “in-line” rating and issued a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Finally, Barclays cut their price objective on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 1st. Twelve analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $171.53.
Insider Buying and Selling
In other news, COO Shailesh Jejurikar sold 13,039 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the completion of the sale, the chief operating officer owned 28,036 shares in the company, valued at approximately $4,409,221.72. This represents a 31.74% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Andre Schulten sold 11,638 shares of Procter & Gamble stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,830,308.26. Following the completion of the transaction, the chief financial officer owned 52,642 shares in the company, valued at $8,279,007.34. The trade was a 18.11% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 150,488 shares of company stock worth $23,529,718. 0.20% of the stock is owned by insiders.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
- Five stocks we like better than Procter & Gamble
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Getting Defensive: 3 Dividend Payers Reporting Strong Q3 Earnings
- Trading Stocks: RSI and Why it’s Useful
- Why Investors Shouldn’t Fear the Dip in Microsoft Stock
- Asset Allocation Strategies in Volatile Markets
- DigitalOcean’s Tide Has Turned: Get Ready to Ride the Wave
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).